Product image of Kosalin (Cyclamen Purpurascens Trit. D 3, Cimicifuga Racemosa Trit D2, Gelsemium Sempervirens Trit. D2, Iris ) supplied by GNH India

Kosalin

Active Ingredient:
Cyclamen Purpurascens Trit. D 3, Cimicifuga Racemosa Trit D2, Gelsemium Sempervirens Trit. D2, Iris
Origin:
EU

Kosalin (Cyclamen Purpurascens Trit. D 3, Cimicifuga Racemosa Trit D2, Gelsemium Sempervirens Trit. D2, Iris)

Cyclamen purpurascens, Cimicifuga racemosa, Gelsemium sempervirens and Iris, the active ingredients in Kosalin, are a homeopathic blend presented as an oral preparation for oral use. It is intended to support mild nervous and respiratory discomfort in adults and may help alleviate occasional symptoms.

GNH India supplies Kosalin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics for global health partners.

Manufacturer / TM Owner

Pharmasgp Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Kosalin, a homeopathic preparation, is used in supportive care for mild nervous system and upper respiratory tract discomfort.
  • Mild anxiety: may help reduce occasional nervous tension.
  • Transient headache: may support relief of brief headache episodes.
  • Common cold symptoms: may assist in easing mild cough and nasal congestion.
  • Menstrual discomfort: may aid in alleviating occasional cramps.

How It Works

  • Kosalin contains highly diluted extracts of Cyclamen purpurascens, Cimicifuga racemosa, Gelsemium sempervirens and Iris. In homeopathy, such dilutions are thought to trigger hormetic responses that stimulate the body's self‑regulatory mechanisms, leading to subtle modulation of symptom perception. The exact molecular targets remain undefined, and the preparation is considered to act via a non‑specific, low‑dose signaling pathway.

Side Effects

Kosalin, like other highly diluted homeopathic medicines, may be associated with a limited range of adverse reactions.

Common Side Effects

  • Mild gastrointestinal upset: occasional nausea or stomach discomfort.
  • Transient taste alteration: brief metallic or bitter taste.
  • Headlight dizziness: short‑lasting light‑headed feeling.

Serious or Rare Side Effects

  • Allergic reaction: rash, itching, or swelling.
  • Anaphylaxis: rare severe hypersensitivity requiring immediate medical attention.
  • Severe skin eruption: uncommon extensive rash or hives.

Precautions & Warnings

  • When considering Kosalin, several safety precautions should be observed.
  • Pregnancy: safety not established; use only if clearly needed.
  • Breastfeeding: caution advised; consult healthcare professional.
  • Allergy: discontinue if hypersensitivity to any ingredient occurs.
  • Concurrent homeopathic products: avoid simultaneous use to prevent overlapping dilutions.
  • Store below 25°C: keep in original pack, protect from moisture.

Avoid Interactions

Kosalin may interact with other medicines, although documented interactions are limited.

Major Interactions (Avoid)

  • None identified: no major pharmacokinetic interactions reported.

Moderate Interactions (Monitor Closely)

  • Concurrent use of CNS depressants: may enhance sedative effect.
  • High‑dose antihistamines: may increase risk of drowsiness.
  • Other homeopathic remedies: may lead to additive dilution effects; monitor clinical response.

Frequently Asked Questions

Kosalin is a homeopathic preparation that contains diluted extracts of Cyclamen purpurascens, Cimicifuga racemosa, Gelsemium sempervirens and Iris. It is generally used to support mild nervous system discomfort, occasional headaches, common‑cold related symptoms and occasional menstrual cramps, always under professional guidance.

In Kosalin, Cyclamen purpurascens is present as a highly diluted extract. Homeopathic theory suggests that such dilutions may stimulate the body’s innate self‑regulatory mechanisms through hormesis, leading to subtle modulation of symptom perception. The precise biological pathways are not fully defined in conventional pharmacology.

The dosage of Kosalin is determined by the prescribing healthcare professional based on individual needs, age, and the specific condition being addressed. No fixed regimen is provided here; patients should follow the instructions given by their clinician or pharmacist.

Safety data for Kosalin in pregnancy and lactation are limited. It should be used only if clearly needed and after consultation with a qualified healthcare provider. Women who are pregnant or breastfeeding should discuss potential risks and benefits with their doctor before starting the product.

To order Kosalin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Kosalin differs from many single‑ingredient homeopathic products by combining four botanical extracts, potentially offering a broader spectrum of subtle therapeutic signals. While the overall safety profile remains similar—generally low risk of side effects—clinical decisions should consider the specific symptom pattern and the practitioner’s experience with multi‑ingredient formulations.

Kosalin should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keeping the product in a cool, dry place helps maintain its stability and ensures the integrity of the highly diluted ingredients.

Kosalin is administered orally. The exact method—such as tablets, drops, or liquid—depends on the commercial form supplied by the manufacturer. Patients should follow the administration instructions provided by their healthcare professional, ensuring the correct dosage form is taken as directed.

Serious risks, although rare, include allergic reactions that may manifest as rash, itching, swelling, or in extreme cases, anaphylaxis. Users should discontinue the product immediately and seek medical attention if any signs of hypersensitivity appear.

Individuals with known hypersensitivity to any of the listed botanical ingredients should avoid Kosalin. Additionally, pregnant or breastfeeding women should only use it after professional medical advice, and patients taking high‑dose CNS depressants should consult a clinician to assess potential additive effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cyclamen Purpurascens Trit. D 3, Cimicifuga Racemosa Trit D2, Gelsemium Sempervirens Trit. D2, Iris

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT